StockData
Chiron Real Estate Inc. logo

Chiron Real Estate Inc. (XRN) company profile

XRNNYSEReal Estate Investment TrustsFiscal year ends December 31Also trades as XRN.PA, XRN.PB
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3076% below fair value
$25.80−0.61 (-2.31%)

Close on Nov 17, 2026Market cap $341.54MP/E 6.9Yield –

About Chiron Real Estate

Real Estate Investment Trusts, SIC 6798

Chiron Real Estate Inc. is an internally managed real estate investment trust that acquires and owns healthcare real estate properties. The company focuses on off-campus medical facilities, small to mid-sized healthcare assets in secondary markets and suburban areas, and residential communities for seniors. Its property types primarily comprise medical office buildings, inpatient rehabilitation facilities, and surgical hospitals, alongside other specialized clinical spaces. Chiron Real Estate leases its facilities mainly to physician practice groups, regional healthcare systems, and national healthcare operators.

The company's real estate portfolio comprises 189 buildings spanning approximately 5.1 million leasable square feet, along with an interest in an unconsolidated joint venture owning two additional healthcare facilities. Chiron Real Estate maintains properties across 35 states in the United States, with notable concentrations in Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois. The provided text states that the entity is a Maryland corporation, but it does not specify its headquarters location.

Summary of the business section of Chiron Real Estate's latest annual report, written by StockData.

Company profile

Company

Legal name
Chiron Real Estate Inc.
Headquarters
Bethesda, MD
Address
7373 Wisconsin Avenue, Suite 800 20814
Phone
(202) 524-6851
Employees
30, Dec 31, 2025
Industry
Real Estate Investment Trusts
Incorporated in
Maryland
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, McLean, VA

Stock & identifiers

Ticker
XRN
Other tickers
XRN.PA, XRN.PB
Former tickers
GMRE until Feb 25, 2026
Exchange
NYSE
IPO date
Jun 30, 2016
Shares outstanding
13M, Aug 3, 2026
Public float
$436.00M, Jun 30, 2025
Filer category
Accelerated filer
Stock splits
1-for-5 reverse, Sep 22, 2025; 1-for-400 reverse, Dec 19, 2014
SEC CIK
1533615
CUSIP
37954A303
ISIN
US37954A3032
FIGI
BBG0027F2B89
Share class FIGI
BBG0027F2C05
LEI
549300HFRIPQDYU3GU60
EIN
46-4757266

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Mark Okey Decker JrCEO and President, Director78,603
Jeffrey BuschChairman, President and CEO, Director43,490
Matthew Fitzsimmons WhitlockChief Investment Officer2,000
Danica HolleyChief Administrative Officer1,590
Aaron Robert RosethCOO13,500
Robert Harold ZeillerSee Remarks–
Jamie Allen BarberGeneral Counsel and Secretary1,481
Robert J. KiernanCFO and Treasurer6,000
Alfonzo LeonCIO–
Charles FitzgeraldDirector138,893
Paula CrowleyDirector1,000
Lori WittmanDirector2,940
Matthew CypherDirector1,690
Ronald MarstonDirector10,596
Henry ColeDirector9,286

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Jeffrey Busch
$328.61K$36.88K$1.22M$78$114
FY2025
Mark Decker Jr
$1.82M$1.95M$1.22M$78$114
FY2024$2.52M$1.95M$1.21M$86$124
FY2023$2.18M$2.52M$1.14M$112$114
FY2022$1.84M-$1.03M$915.64K$88$100
FY2021$1.51M$2.87M$751.96K$152$132

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Mark Decker, Jr.
Chief Executive Officer, Director
$371.39K$1.15M$222.83K$75.00K$1.82M–
Jeffrey Busch
Former Chief Executive Officer, Chairman
$328.61K–––$328.61K-87%
Robert Kiernan
Chief Financial Officer
$400.00K$910.00K$213.20K–$1.52M+1%
Alfonzo Leon
Chief Investment Officer
$375.00K$900.00K$199.80K–$1.47M+1%
Danica Holley
Chief Operating Officer
$325.00K$524.00K$138.53K–$987.53K+1%
Jamie Barber
General Counsel & Corporate Secretary
$290.00K$492.80K$123.61K–$906.41K+1%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Jun 30, 2016
Offer price
$10.00
Securities offered
13,043,479
Gross proceeds
$130.43M
Exchange
NYSE
Lock-up ends (est.)
Dec 27, 2016

“We are offering 13,043,479 shares of our common stock, $0.001 par value per share for an initial public offering price of $10.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, the Company had 30 employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Nov 5, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 5, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 17, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 2, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 2, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 26, 2026Name changeName changed from Global Medical REIT Inc. to Chiron Real Estate Inc.
Nov 18, 2025ListingRegistration of securities on an exchange (Form 8-A)
Jul 9, 2020Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 18, 2019Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 12, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 24, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 29, 2017Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 14, 2017ListingRegistration of securities on an exchange (Form 8-A)
Jul 6, 2017Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 5, 2017Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 23, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 22, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 30, 2016IPOInitial public offering priced (424B4 prospectus)
Jun 28, 2016ListingRegistration of securities on an exchange (Form 8-A)
Apr 6, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 3, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 7, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 26, 2015Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 1, 2015Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 1, 2014Late filingNotification of late filing
Sep 15, 2014Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 6, 2014Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 15, 2014Late filingNotification of late filing
Jun 12, 2014Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 15, 2014Late filingNotification of late filing

See a number that looks wrong?